DMK Pharmaceuticals Corp
DMKDelisted Mar 21, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000887247
DMK Pharmaceuticals Corp was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 29 institutions reported holding it in 13F filings for Q4 2023, worth $350.4K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by DMK Pharmaceuticals Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for DMK Pharmaceuticals Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Dorbin John W. Jr. | General Counsel | – | Nov 2, 2023 | 0 |
| Cohen Seth | CFO | – | Oct 25, 2023 | 0 |
| Versi Ebrahim | CEO | 906,394Indirect | Sep 19, 2023 | 0 |
| Desai Meera J. | Director | 3,138 | May 30, 2023 | 0 |
| Versi Jannine | Director | 177,194Indirect | May 30, 2023 | 0 |
| Birndorf Howard C | Director | – | Nov 16, 2022 | 0 |
| Carlo Dennis J PhD | Other: Former President & CEO | 535,867 | May 27, 2022 | 0 |
| Reed Vickie S | Director | – | May 26, 2022 | 0 |
| Marguglio David J. | SVP and Chief Business Officer | 233,906 | Mar 22, 2022 | 0 |
| Moss Ronald B. | Chief Medical Officer | 201,911 | Mar 22, 2022 | 0 |
| Benedicto David C. | Chief Financial Officer | 39,875 | Mar 22, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 3, 2021 (view filing) | Dec 1 | 2 days | Carlo Dennis J PhDPresident & CEO | SSale | −47.9K | $0.79 | −$37.8K | −13.9%296.4K after | |
| Dec 3, 2021 (view filing) | Dec 1 | 2 days | Marguglio David J.SVP and Chief Business Officer | SSale | −50.8K | $0.79 | −$40.1K | −16.4%258.8K after | |
| Dec 3, 2021 (view filing) | Dec 1 | 2 days | Moss Ronald B.Chief Medical Officer | SSale | −35.6K | $0.79 | −$28.1K | −14.5%210.1K after | |
| Dec 3, 2021 (view filing) | Dec 1 | 2 days | Benedicto David C.Chief Financial Officer | SSale | −13.6K | $0.79 | −$10.7K | −23.8%43.5K after | |
| Mar 22, 2022 (view filing) | Mar 18 | 4 days | Benedicto David C.Chief Financial Officer | SSale | −3.60K | $0.61 | −$2.20K | −8.3%39.9K after | |
| Mar 22, 2022 (view filing) | Mar 18 | 4 days | Carlo Dennis J PhDPresident & CEO | SSale | −10.5K | $0.60 | −$6.29K | −3.5%285.9K after | |
| Mar 22, 2022 (view filing) | Mar 18 | 4 days | Marguglio David J.SVP and Chief Business Officer | SSale | −11.9K | $0.60 | −$7.12K | −4.8%233.9K after | |
| Mar 22, 2022 (view filing) | Mar 18 | 4 days | Moss Ronald B.Chief Medical Officer | SSale | −8.20K | $0.60 | −$4.92K | −3.9%201.9K after |